drugset / Trial / NCT02291471

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

NCT02291471

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study to assess the MTD and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers.

Timeline

Start
2014-10
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject T0001 Protein / enzyme biologic 10 mg
Subject T0001 Protein / enzyme biologic 20 mg
Subject T0001 Protein / enzyme biologic 35 mg
Subject T0001 Protein / enzyme biologic 50 mg
Subject T0001 Protein / enzyme biologic 65 mg
Subject T0001 Protein / enzyme biologic 75 mg

Indications